Promoting Inclusive Excellence In Medicine


Our mission is to build a broadly diverse faculty, student and staff community and to promote a culture that is welcoming and inclusive, and at the forefront of working to achieve health equity in the communities we serve.


training

Professional Development

We provide a wide variety of personal and professional development activities as well as consultation services for the Larner College of Medicine community.

gates

Signature Events

From internationally-known guest lecturers, to community celebrations Learn more >>


Find Us on Facebook


Moses’ Study on Fecal Transplant Cure for Gl Disorders Featured in 7Days

March 23, 2017 by Kate Skins

Clostridium difficile, commonly known as C. diff, affects nearly half a million Americans a year, and leads to several thousand fatalities, according to the CDC. This infection is difficult to treat, especially among those with an antibiotic-resistant strain, but Peter Moses, M.D., professor of medicine at the Larner College of Medicine and gastroenterologist at the UVM Medical Center, uses fecal microbiota transplantation (FMT) as a solution.

Peter Moses, M.D., professor of medicine at the Larner College of Medicine and gastroenterologist at the UVM Medical Center (Photo: LCOM Creative Services)

(MARCH 15, 2017) Clostridium difficile, commonly known as C. diff, affects nearly half a million Americans a year, and leads to several thousand fatalities, according to the CDC. This infection is difficult to treat, especially among those with an antibiotic-resistant strain, but Peter Moses, M.D., professor of medicine at the Larner College of Medicine and gastroenterologist at the UVM Medical Center, uses fecal microbiota transplantation (FMT) as a solution. With a 90% success rate in curing C. diff in his patients, Dr. Moses is now setting his sights on using this procedure to cure other gastrointestinal and autoimmune disorders. Read more about his study in Seven Days.